Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
02/2003
02/12/2003EP1282700A1 Neuronal serine-threonine protein kinase
02/12/2003EP1282692A2 Sentinel virus ii
02/12/2003EP1282691A1 Method for preventing allograft rejection
02/12/2003EP1282646A2 Human monoclonal antibodies to dendritic cells
02/12/2003EP1282642A2 Therapeutic pore-forming peptides
02/12/2003EP1282449A2 Treatment of human papillomavirus (hpv)-infected cells
02/12/2003EP1282448A1 Heterobifunctional cross-linking agent conjugate substituted by an immunomodulator and cell recognition unit
02/12/2003EP1282444A1 Antithrombotic agents
02/12/2003EP1282443A1 Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy
02/12/2003EP1282442A1 Cancer treatments by using a combination of an antibody against her2 and interleukin-2
02/12/2003EP1282440A1 Aromatase inhibitors and monoclonal anti-her2 antibodies as antitumor agents
02/12/2003EP1282415A2 Compounds and methods for regulating bacterial growth and pathogenesis
02/12/2003EP1282403A1 Non-invasive gene targeting to the brain
02/12/2003EP0969877B1 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections
02/12/2003EP0694068B1 Genetic suppressor elements associated with sensitivity to chemotherapeutic drugs
02/12/2003CN1396927A Method for preparing polypeptide soluble in aqueous solvent in absence of detergent
02/12/2003CN1396832A Pre-transplant accommodated organs resistant to anti-donor immunity
02/12/2003CN1396258A Recopulated strain of rotavirus gene
02/12/2003CN1396183A Human fusion antibody for reducing cerebral amyloid fibers associated with senile dementia
02/12/2003CN1395967A Grassland locoism toxin vaccine
02/12/2003CN1101404C Anti Bacillus pyocyaneu vitelline immunoglobulin products and use thereof
02/12/2003CN1101226C 疫苗 Vaccine
02/12/2003CN1101225C 乙肝疫苗 Hepatitis B vaccine
02/11/2003US6518256 Compounds and methods for therapy and diagnosis of lung cancer
02/11/2003US6518239 Dry powder compositions having improved dispersivity
02/11/2003US6518237 Compositions for treatment and diagnosis of breast cancer and methods for their use
02/11/2003US6518063 Osf2/Cbfa1 nucleic acids and methods of use therefor
02/11/2003US6518061 Interleukin-13 (IL-13); Delivery of a modified Pseudomonas exotoxin (effector molecule), attached to an interleukin, to tumor cells bearing interleukin receptors; antitumor agent
02/11/2003US6518043 Proteins suppressing proliferation of lympho-hematopoietic cells
02/11/2003US6518031 Hapten-carrier conjugates for treating and preventing nicotine addiction
02/11/2003US6518030 Non-infectious, retrovirus-like particles comprise an assembly of an env gene product, a pol gene product and a gag gene product contain an antigenic marker which is non-retroviral or non-HIV retroviral. In one embodiment, the
02/11/2003US6518028 Methods for the early diagnosis of ovarian and prostate cancer
02/11/2003US6518015 Peptide comprising the sequence CAFRQVC and methods using it
02/11/2003US6518013 Methods for the inhibition of epstein-barr virus transmission employing anti-viral peptides capable of abrogating viral fusion and transmission
02/11/2003US6517844 Inactivated bordetella avium or ornithobacterium rhino-tracheale bacterin and a preservative; oral administration with water
02/11/2003US6517843 Recombinant immunogen comprised of an inactivated porcine circovirus-2
02/11/2003US6517842 Marburg virus vaccines
02/11/2003US6517839 Immune response to intracellular pathogens or interferon gamma-sensitive tumors; Mycobacterium tuberculosis;lipopeptide N-terminal ester- or amide-linked fatty acyl group, Xaa-Ser-Ser-Asn-Lys-Ser; Xaa is an N-acyldiacylglycerolcysteine
02/11/2003US6517838 Protecting against infection with Borrelia burgdorferi, Lyme disease
02/11/2003US6517835 Growth differentiation factor-11
02/11/2003US6517834 Purified telomerase
02/11/2003US6517833 Vision defects
02/11/2003CA2174529C Dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) and uses thereof
02/11/2003CA2170509C Dna encoding prostaglandin receptor ep2
02/11/2003CA2162880C Composite synthetic peptide construct eliciting neutralizing antibodies and cytotoxic t lymphocytes against hiv
02/11/2003CA2152667C Bone resorption assay
02/11/2003CA2139645C Immunoassays for anti-hcv antibodies using antigens with conformational epitopes
02/11/2003CA2133843C Melanocyte stimulating hormone receptor and uses
02/11/2003CA2078689C Chimeric antibodies with receptor binding ligands in place of their constant region
02/11/2003CA2058386C Cell free marek's disease virus vaccine
02/11/2003CA2005704C Pneumolysin mutants and pneumococcal vaccines made therefrom
02/08/2003CA2354255A1 Compositions and methods for eliciting immune responses with a secretion-directed protein
02/06/2003WO2003010317A1 Novel peptides of the respiratory syncytial virus (rsv) g protein and their use in a vaccine
02/06/2003WO2003010315A1 Abca7 splicing variant
02/06/2003WO2003010313A1 Novel diphtheria anatoxins and their use as carrier
02/06/2003WO2003010301A1 New isolated dendritic cells, a process for preparing the same and their use in pharmaceutical compositions
02/06/2003WO2003010298A1 'probiotic lactobacillus salivarius strains
02/06/2003WO2003010291A2 Treatment of immune disorders and b cell disorders
02/06/2003WO2003010290A2 Novel class ii cytokine receptors and uses thereof
02/06/2003WO2003010282A2 Interleukin-1 beta antibodies
02/06/2003WO2003010201A2 Blood group antigen fusion polypeptides and methods of use thereof
02/06/2003WO2003010195A2 Novel compounds
02/06/2003WO2003010194A2 Meningococcus adhesins nada, app and orf 40
02/06/2003WO2003009869A1 Vaccines comprising aluminium adjuvants and histidine
02/06/2003WO2003009868A1 Antigenic compositions
02/06/2003WO2003009867A1 Use of biologically active hiv-1 tat, fragments or derivates thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases
02/06/2003WO2003009817A2 Stable lyophilized pharmaceutical formulation of igg antibodies
02/06/2003WO2003009812A2 Use of glycosylceramides as adjuvants for vaccines against infections and cancer
02/06/2003WO2003009803A2 Method of improving cognitive function
02/06/2003WO2003009784A1 Ophthalmic drug delivery device
02/06/2003WO2003009779A2 Delivery of therapeutic capable agents
02/06/2003WO2003009778A2 Methods and devices for delivery of therapeutic capable agents with variable release profile
02/06/2003WO2003009777A2 Delivery of therapeutic capable agents
02/06/2003WO2003009704A2 Enteral compositions for the prevention and/or treatment of sepsis
02/06/2003WO2002092627A3 Use of casb 7439 for treatment and diagnosis of lung cancer
02/06/2003WO2002090558A9 Novel expression vectors and uses thereof
02/06/2003WO2002072805A3 Thymidylate synthase
02/06/2003WO2002070001A3 Use of lp82 to treat hematopoietic disorders
02/06/2003WO2002064112A3 Therapeutic agents complexed with calcium phosphate and encased by casein
02/06/2003WO2002049666A3 Mycoplasma hyopneumoniae bacterin vaccine
02/06/2003WO2002042317A3 Method of separating extra-chromosomal dna from other cellular components
02/06/2003WO2002040639A3 Methods for enhancing engraftment of purified hematopoietic stem cells in allogeneic recipients
02/06/2003WO2002037961A3 Methods and compositions for the control of coccidiosis
02/06/2003WO2002028904A3 Human anti-cd40 antibodies
02/06/2003WO2002026240A9 Inhibition of antigen presentation with poorly catabolized polymers
02/06/2003WO2002021996A3 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators
02/06/2003WO2002020722A3 Methods and compositions for in vitro targeting
02/06/2003WO2002016602A3 Compositions and methods for the diagnosis and treatment of tumor
02/06/2003WO2002016413A8 Cripto tumour polypeptide
02/06/2003WO2002014470A3 Expression of herstatin, an alternative her-2/neu product, in cells that express either p185her-2 or the egf receptor inhibits receptor activity and cell growth
02/06/2003WO2002010217A9 Endothelial cell expression patterns
02/06/2003WO2002000883A3 Rescue of canine distemper virus from cdna
02/06/2003WO2001066139A9 Use of a compound that selectively binds to cd123 to impair hematologic cancer progenitor cell
02/06/2003WO2001064874A9 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis
02/06/2003WO2001004335A8 Human-bovine chimeric respiratory syncytial virus vaccines
02/06/2003US20030028010 Viral nucleotide sequene clone for use as tool in the treatment of viral diseases
02/06/2003US20030028007 Vascular endothelial growth factor 2
02/06/2003US20030028006 Cytokine receptor common gamma chain like
02/06/2003US20030028000 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferative disorders
02/06/2003US20030027999 143 human secreted proteins
1 ... 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 ... 1823